Alzamend Neuro, Inc. (ALZN)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.04M |
| Enterprise value | 2.76M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 7.23 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.13 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.03 |
| 52-week change 3 | -94.39% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 72.0000 |
| 52-week low 3 | 3.2700 |
| 50-day moving average 3 | 4.7869 |
| 200-day moving average 3 | 10.0342 |
Share statistics
| Avg vol (3-month) 3 | 12.28k |
| Avg vol (10-day) 3 | 26.2k |
| Shares outstanding 5 | 798.18k |
| Implied shares outstanding 6 | 798.18k |
| Float 8 | 578.24k |
| % held by insiders 1 | 25.53% |
| % held by institutions 1 | 4.85% |
| Shares short (15 Jul 2024) 4 | 7.61k |
| Short ratio (15 Jul 2024) 4 | 0.87 |
| Short % of float (15 Jul 2024) 4 | 3.33% |
| Short % of shares outstanding (15 Jul 2024) 4 | 0.95% |
| Shares short (prior month 14 Jun 2024) 4 | 9.51k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 16 Jul 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Apr 2023 |
| Most-recent quarter (mrq) | 31 Jan 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -166.84% |
| Return on equity (ttm) | -1,196.26% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -12.35M |
| Net income avi to common (ttm) | -12.4M |
| Diluted EPS (ttm) | -18.2000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 282.87k |
| Total cash per share (mrq) | 0.41 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.16 |
| Book value per share (mrq) | -6.34 |
Cash flow statement
| Operating cash flow (ttm) | -9.08M |
| Levered free cash flow (ttm) | -4.58M |
© 2024 Yahoo. All rights reserved.